Avansdose

Ankleshwar, India Founded: 2020 • Age: 6 yrs
Manufactures and supplies oncology APIs with RD and quality control standards.

About Avansdose

Avansdose is a Healthcare company based in Ankleshwar (India) founded in 2020. It manufactures and supplies oncology APIs with RD and quality control standards. It operates on a B2B model. Its Indian entity Avansdose Pharmatech Private Limited reported revenue of β‚Ή12.71 Cr. Avansdose offers products and services including Oncology API and Synthesis Peptides. Its focus areas include Healthcare and Pharmaceuticals, API Manufacturing, Oncology and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

AvansDose specializes in manufacturing high-quality oncology APIs, emphasizing cost-effectiveness and adherence to Good Manufacturing Practices. They operate RD facilities focused on oncology products and expanding to peptides. Located in Hyderabad, India, they ensure compliance with environmental and safety regulations while supplying APIs for life-saving drugs to global clients.

  • Headquarters Ankleshwar, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website avansdose.com
  • Legal Name Avansdose Pharmatech Private Limited
  • Date of Incorporation 27 Feb, 2017
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹12.71 Cr

    FY 2025 · -26% YoY

  • Net Loss
    -₹49.4 Lakh

    FY 2025 · -4% margin

  • EBITDA
    -₹43.5 Lakh

    FY 2025 · -3% margin

Products & Services of Avansdose

Avansdose offers a comprehensive portfolio of products and services, including Oncology API and Synthesis Peptides.

Oncology API
API Manufacturing

Produces high-quality APIs for oncology drugs and treatments.

Synthesis Peptides
Biopharmaceuticals

Develops peptides for various therapeutic categories.

Board of directors of Avansdose Pharmatech Private Limited (Avansdose)

Avansdose Pharmatech Private Limited is the primary company behind Avansdose. The board of Avansdose Pharmatech Private Limited currently have 2 directors; the longest-serving is Ravindra Balwani, appointed in 2017.

DirectorDesignationAppointedTenureEntity
Ravindra Balwani
DIN 02115242
Director27 Feb 20179 yrs 8 moAvansdose Pharmatech Private Limited
Gagan Jot Singh
DIN 05271026
Director27 Feb 20179 yrs 8 moAvansdose Pharmatech Private Limited

Financials of Avansdose

Figures of Avansdose Pharmatech Private Limited, the primary company behind Avansdose, for FY 2025. Revenue was ₹12.71 Cr (-26% year on year). Net loss was -₹49.4 Lakh (-4% margin). EBITDA was -₹43.5 Lakh (-3% margin). Revenue has grown at a compounded annual rate of +6% over three years and +186% over five years.

  • ₹12.71 CrRevenue · FY 2025 · -26% YoY
  • -₹49.4 LakhNet loss · -4% margin
  • -₹43.5 LakhEBITDA · -3% margin
  • ₹10,000Paid-up capital
  • +6%Revenue CAGR, 3 years
  • +186%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Avansdose Pharmatech Private Limited are on its company page.

Premium access

Detailed financial statements for Avansdose

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Avansdose

Avansdose has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Avansdose

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Avansdose

Avansdose was founded in 2020.

Avansdose is headquartered in Ankleshwar, India. It is registered at Ankleshwar, Gujarat, India.

The primary company behind Avansdose, Avansdose Pharmatech Private Limited, reported revenue of β‚Ή12.71 Cr for FY 2025, down 26% year on year.

AvansDose specializes in manufacturing high-quality oncology APIs, emphasizing cost-effectiveness and adherence to Good Manufacturing Practices. They operate RD facilities focused on oncology products and expanding to peptides. Located in Hyderabad, India, they ensure compliance with environmental and safety regulations while supplying APIs for life-saving drugs to global clients.

Avansdose's top competitors include Laurus Labs, Symbiotec and SeQuent.

Avansdose offers Oncology API and Synthesis Peptides.

Avansdose operates through Avansdose Pharmatech Private Limited.

The legal entities of Avansdose currently have 2 directors, including Ravindra Balwani, Gagan Jot Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available